Its key to watch patients closely and adjust treatment if needed
The secondary outcomes included the changes in serum sodium levels at 1, 6, 24, and 48 h after 3%NaCl administration, time to symptom improvement, the total amount of intravenous fluid administered, hospital length of stay, total urine volume, and safety outcomes
Stack protocol: BPC-157: 250 to 500 mcg subcutaneous, once or twice a day Inject near the injury when you can reach it TB-500: 2 to 2.5 mg subcutaneous, twice a week (loading phase) Inject away from the injury, lower abdomen or outer thigh works fine 2 mg once a week (maintenance phase) Both run at the same time through the loading phase
We refer readers to the CY 2008 OPPS/ASC final rule with comment period (72 FR 66687) in which we discuss our rationale for applying these rounding principles